期刊文献+

利培酮对精神分裂症首次发病患者认知功能及生活技能的影响 被引量:24

Effects of risperidone on the cognitive function and performance-based skills in drug naive first-episode schizophrenia patients
下载PDF
导出
摘要 目的:评估利培酮对精神分裂症首次发病患者认知功能、生活技能改善及影响因素。方法:对首发精神分裂症住院患者105例接受利培酮治疗10周;使用精神分裂症认知功能成套测验中文版(MCCB)、Stroop等测验评估认知功能;加州大学圣地亚哥分校基于任务的生活能力测验(UPSA)评估生活技能;阳性和阴性症状量表(PANSS)评估精神症状。结果:与基线比较,治疗后MCCB中连线分数、符号编码、空间广度、数字序列、迷宫、视觉记忆、情绪管理、MCCB总分、Stroop测验得分均提高,差异有统计学意义(P均〈0.05);UPSA总分、财务技能、交流技能得分均提高,差异有统计学意义(P均〈0.05);Logistic Regression回归分析显示MCCB疗效与基线PANSS总分存在关联(β=0.03,Wald=4.80,P=0.028,95%CI1.003~1.057)。结论:利培酮对精神分裂症首次发病患者认知功能及生活技能均有改善作用,认知功能改善程度可能与临床症状无关。 Objective: To evaluate effects of risperidone on the cognitive function and performance-based skills and related influencing factors in drug-naive first-episode schizophrenia patients. Method: One hundred and five inpatients schizophrenia patients received 10 weeks treatment of single reperidone. Patients were assessed with MATRICS consensus cognitive battery( MCCB),Stroop,University of Califomia San Diego performance-based skill assessment( UPSA),positive and negative syndrome scale( PANSS). Results: Compared with baseline,MCCB total score,trail making test,symbol coding,spatial span,digit sequencing,mazes,visuospatial memory,managing emotions and stroop score were significantly increased at week 10( P all〈 0. 05). UPSA total score,financial skill and communication skill subscore were significantly increased at week 10 than baseline( P all〈 0. 05). Logistic regression showed that MCCB improvement was associated with PANSS total score at baseline( β = 0. 03,Wald = 4. 80,P = 0. 028,95% CI: 1. 003 ~ 1. 057). Conclusion: Risperidone can improve cognitive function of patients with first-episode,drug-naive schizophrenia. Improvement of cognitive function could be associated with psychotic symptoms.
机构地区 北京回龙观医院
出处 《临床精神医学杂志》 2016年第2期115-117,共3页 Journal of Clinical Psychiatry
基金 美国国立精神卫生研究所(NIMH)资助项目(H-22473)
关键词 首发精神分裂症 认知功能 非典型抗精神病药 生活技能 first-episode schizophrenia patients cognition atypical antipsychotic living skill
  • 相关文献

参考文献8

  • 1Kern RS, Gold J M, Dickinson D, et al. The MCCB impairment pro- file for schizophrenia outpatients : results from the MATRICS psy- chometric and standardization study [ J ]. Schizophr Res, 2011,126 (1/3) :124-131.
  • 2McCleery A, Ventura J, Kern RS, et al. Cognitive functioning in first-episode schizophrenia: MATRICS consensus cognitive battery (MCCB) profile of impairment [ J ]. Schizophrenia Res, 2014,157 (1/3) :33-39.
  • 3Johnson MK, McMahan RP, Robinson BM, et al. The relationshipbetween working memory capacity and broad measures of cognitive ability in healthy adults and people with schizophrenia[ J]. Neuro- psychology, 2013,27 ( 2 ) : 220 -229.
  • 4Mausbach BT, Harvey PD, Goldman SR, et al. Development of a brief scale of everyday functioning in persons with serious mental illness[ J]. Schizophr Bull ,2007,33 (6) : 1364-1372.
  • 5邹义壮,崔界峰,王健,陈楠,谭淑平,张东,徐泽,宋少刚,王云辉,李玥,高文静,段京辉.精神分裂症认知功能成套测验中文版临床信度及效度的研究[J].中华精神科杂志,2009,42(1):29-33. 被引量:173
  • 6崔界峰,邹义壮,王健,陈楠,范宏振,姚晶,段京辉.加州大学圣地亚哥分校基于任务的生活能力测验简版的临床信效度[J].中国心理卫生杂志,2012,26(8):577-583. 被引量:13
  • 7Davidson M, Galderisi S,Weiser M, et al. Cognitive effects of antip- sychotic drugs in first-episode schizophrenia and schizophreniform disorder:a randomized, open-label clinical trial (EUFEST) [ J]. Am J Psychiatry. 2009.166 ( 6 ) :675-682.
  • 8王长虹,李晏,苏林雁,马建东,穆俊林.奥氮平、利培酮对首发精神分裂症患者记忆功能及P300的影响[J].中国神经精神疾病杂志,2009,35(8):481-484. 被引量:20

二级参考文献51

  • 1安宝富,王长虹,李晏.利培酮对精神分裂症认知功能和血清细胞因子水平的影响[J].中国神经精神疾病杂志,2006,32(3):249-252. 被引量:10
  • 2Yamashita C, Mizuno M, Nemoto T, et al. Social cognitive problem-solving in schizophrenia: associations with fluency and verbal memory. Psychiatry Res, 2005, 134 : 123-129.
  • 3Penades R, Boget T, Catalon R, et al. Cognitive mechanisms, psychosocial functioning, and neurocognitive rehabilitation in schizophrenia. Schizophr Res, 2003,63:219-227.
  • 4Marder SR, Fenton W. Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophr Res, 2004, 72:5-9.
  • 5Kern RS, Green MF, Nuechterlein KH, et al. NIMH-MATRICS survey on assessment of neurocognition in schizophrenia. Schizophr Res, 2004,72:11-19.
  • 6Green MF, Nueehterlein KH. The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr Res, 2004, 72 : 1-3.
  • 7Green MF, Nuechterlein KH, Gold JM, et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry, 2004,56:301-307.
  • 8Nuechterlein KH, Barch DM, Gold JM, et al. Identification of separable cognitive factors in schizophrenia. Schizophr Res, 2004, 72:29-39.
  • 9Nuechterlein KH, Green MF, Kern RS, et al. The MATRICS Consensus Cognitive Battery, part 1 : test selection, reliability, and validity. Am J Psychiatry, 2008,165:203-313.
  • 10Kern RS, Nuechterlein KH, Green MF, et al. The MATRICS Consensus Cognitive Battery, part 2 : eo-norming and standardization. Am J Psychiatry, 2008,165:214-220.

共引文献195

同被引文献181

引证文献24

二级引证文献189

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部